170 related articles for article (PubMed ID: 20950840)
1. Monitoring treatments with unfractionated heparin: CTAD must be used instead of citrate as the anticoagulant solution when using partial-draw collection tubes. Results of a multicenter evaluation.
Toulon P; Abecassis L; Smahi M; Ternisien C
Thromb Res; 2010 Dec; 126(6):536-42. PubMed ID: 20950840
[TBL] [Abstract][Full Text] [Related]
2. [Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?].
Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
Ann Biol Clin (Paris); 2020 Feb; 78(1):27-34. PubMed ID: 32108577
[TBL] [Abstract][Full Text] [Related]
3. Underestimation of unfractionated heparin therapy assessment due to platelet activation when using partial-draw (pediatric) citrate collection tubes.
Desconclois C; Eschwège V; Proulle V; Boutekedjiret T; Dreyfus M; Toulon P
Thromb Res; 2014 Nov; 134(5):1117-22. PubMed ID: 25248688
[TBL] [Abstract][Full Text] [Related]
4. Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?
Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
J Thromb Thrombolysis; 2019 Aug; 48(2):277-283. PubMed ID: 31098816
[TBL] [Abstract][Full Text] [Related]
5. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
Toulon P; Ajzenberg N; Smahi M; Guillin MC
Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
[TBL] [Abstract][Full Text] [Related]
6. A low volume specimen container suitable for monitoring the aPTT of heparinized patients.
Ray MJ; Carroll PA; Just SJ; Hawson GA
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):805-7. PubMed ID: 8292732
[TBL] [Abstract][Full Text] [Related]
7. Monitoring unfractionated heparin with APTT: a French collaborative study comparing sensitivity to heparin of 15 APTT reagents.
Gouin-Thibaut I; Martin-Toutain I; Peynaud-Debayle E; Marion S; Napol P; Alhenc-Gelas M;
Thromb Res; 2012 May; 129(5):666-7. PubMed ID: 22169771
[No Abstract] [Full Text] [Related]
8. [Prescription and monitoring of anticoagulant therapies].
Laviolle B; Oger E
Rev Prat; 2008 Nov; 58(18):2063-70. PubMed ID: 19143281
[No Abstract] [Full Text] [Related]
9. Evaluation of CTAD (citrate-theophylline-adenosine-dipyridamole) as a universal anticoagulant in dogs.
Granat FA; Geffré A; Lucarelli LA; Braun JD; Trumel C; Bourgès-Abella NH
J Vet Diagn Invest; 2017 Sep; 29(5):676-682. PubMed ID: 28673194
[TBL] [Abstract][Full Text] [Related]
10. Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixture.
Contant G; Gouault-Heilmann M; Martinoli JL
Thromb Res; 1983 Jul; 31(2):365-74. PubMed ID: 6636048
[TBL] [Abstract][Full Text] [Related]
11. Photochemical decomposition of dipyridamole in aqueous solution and the utilization of citrate-theophylline-adenosine-dipyridamole anticoagulant for monitoring of heparin.
van den Besselaar AM
Int J Lab Hematol; 2010 Apr; 32(2):265-7. PubMed ID: 19552650
[No Abstract] [Full Text] [Related]
12. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
Macey M; McCarthy D; Azam U; Milne T; Golledge P; Newland A
Cytometry B Clin Cytom; 2003 Jan; 51(1):30-40. PubMed ID: 12500295
[TBL] [Abstract][Full Text] [Related]
13. Monitoring heparin anticoagulation in the acute phase response.
Uprichard J; Manning RA; Laffan MA
Br J Haematol; 2010 May; 149(4):613-9. PubMed ID: 20230412
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different anticoagulant associations on haemostasis and biochemical analyses in feline blood specimens.
Granat F; Monzali C; Jeunesse E; Guerlin M; Trumel C; Geffré A; Bourgès-Abella N
J Feline Med Surg; 2017 Apr; 19(4):394-402. PubMed ID: 26887655
[TBL] [Abstract][Full Text] [Related]
15. Heparin and citrate additive carryover during blood collection.
Keppel MH; Auer S; Lippi G; von Meyer A; Cornes M; Felder TK; Oberkofler H; Mrazek C; Haschke-Becher E; Cadamuro J
Clin Chem Lab Med; 2019 Nov; 57(12):1888-1896. PubMed ID: 31377734
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of a bilayer polymer blood collection tube for coagulation testing: effect on routine hemostasis test results and on plasma levels of coagulation activation markers.
Toulon P; Aillaud MF; Arnoux D; Boissier E; Borg JY; Gourmel C
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):625-31. PubMed ID: 17102648
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo neutralization of unfractionated heparin for assessing overall haemostatic potential in patient plasma.
Božič-Mijovski M; Vučnik M; Boc V; Blinc A; Stegnar M
Thromb Res; 2015 May; 135(5):1042-4. PubMed ID: 25805163
[No Abstract] [Full Text] [Related]
18. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system.
Macey M; Azam U; McCarthy D; Webb L; Chapman ES; Okrongly D; Zelmanovic D; Newland A
Clin Chem; 2002 Jun; 48(6 Pt 1):891-9. PubMed ID: 12029005
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation monitoring.
Ng VL
Clin Lab Med; 2009 Jun; 29(2):283-304. PubMed ID: 19665679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
